340B Advocacy Alliance Bulletin
AHA Defends HHS Court Decision on 340B Rebate Model
The Health Resources and Services Administration (HRSA) July 31 announced a 340B rebate model pilot program that will provide certain drugmakers the option to effectuate access to 340B discounted pricing for certain drugs under a rebate model.
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug manufacturers to effectuate the 340B ceiling price on select drugs to all 340B covered entities.
Register for Aug. 1 AHA Site-neutral Advocacy Alliance Call.
The AHA 340B Alliance July 29 at 3 p.m. ET will host a call for AHA members about 340B proposals contained in the hospital outpatient prospective payment system and physician fee schedule proposed rules for calendar year 2026.
340B Advocacy Alliance Bulletin for July 17, 2025.
A U.S. District Court for the District of Columbia judge today ruled against Johnson and Johnson and sided with the Department of Health and Human Services and hospitals in a lawsuit brought by J&J challenging the government’s authority to reject J&J’s proposed 340B rebate model.
AHA Post-Acute Care Advocacy Alliance News Update - June 13, 2025
340B Advocacy Alliance Bulletin for June 13, 2025
340B Advocacy Alliance Bulletin for May 14, 2025.